Sarepta Therapeutics | SCHULD



Debt Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 60.1B 299M 2024-12
Biogen USD 6.3B 1.9M 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Daiichi Sankyo JPY 101.43B 94M 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
Incyte USD 37.96M 5.81M 2024-12
Insmed USD 1.13B 147.86M 2024-12
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
Moderna USD 62M 593M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Pfizer USD 64.35B 3.35B 2024-12
PTC Therapeutics USD 2.39B 389K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 23.75B 5.33B 2024-06
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Tectonic Therapeutic USD 991K 120K 2024-09
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Sarepta Therapeutics SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.